Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2012
06/13/2012EP2215068B1 Antidiabetic tricyclic compounds
06/13/2012EP1989205B1 Thiophene-carboxamides useful as inhibitors of protein kinases
06/13/2012EP1809629B1 N,N'-diphenyl urea derivatives suitable for the treatment of tumours, eye diseases, inflammation and diseases of the immune system
06/13/2012EP1363705B1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
06/13/2012CN1997642B 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
06/13/2012CN1968955B Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors
06/13/2012CN102498111A Sulfonamides as inhibitors of Bcl-2 family proteins for the treatment of cancer
06/13/2012CN102498091A Glycine compound
06/13/2012CN102491974A Method for synthesizing 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-formamidine hydrochloride
06/13/2012CN102093352B Key intermediate for minodronate, method for synthesizing key intermediate and method for synthesizing minodronate with intermediate
06/13/2012CN101675042B Novel 2-heteroaryl substituted benzothiophenes and benzofuranes 709
06/13/2012CN101553487B Substituted 3-isobutyl-9, 10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a] isoquinolin-2-ol compounds and methods relating thereto
06/13/2012CN101356172B Kinase inhibitors
06/13/2012CN101014598B Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
06/12/2012US8198449 Compounds for the treatment of hepatitis C
06/12/2012US8198447 Fused tricyclic compound having aldose reductase inhibitory activity
06/12/2012US8198441 Process for the preparation of novel pyridopyrazines as mTOR kinase inhibitors
06/12/2012US8198307 Imidazole derivatives having aryl piperidine substituent, method for preparation thereof and pharmaceutical compositions containing same
06/12/2012US8198298 Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors
06/12/2012US8198295 Benzonaphthyridines
06/12/2012US8198290 Methoxatin derivatives
06/12/2012US8198282 Substituted azaquinazolines having an antiviral action
06/12/2012US8198279 Pyrido[2,3-b]pyrazin-8-substituted compounds and their use
06/12/2012US8198273 Compounds and methods for kinase modulation, and indications therefor
06/12/2012CA2647596C Pyrrolo- and thiazolo-pyridine compounds as hif modulators
06/07/2012WO2012075492A2 Carbocycle-substituted purine and 7-deazapurine compounds
06/07/2012WO2012075235A1 Alkyl amides as hiv attachment inhibitors
06/07/2012WO2012075115A1 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2
06/07/2012WO2012075048A2 Hybrid cyclic libraries and screens thereof
06/07/2012WO2012074769A1 3-substituted-6-(pyridinylmethoxy)-pyrrolopyridine compounds
06/07/2012WO2012072727A1 Crystalline modification of n-(3,5-dichloropyridin-4-yl)-[1-(4 -fluorobenzyl)-7-azaindol-3-yl)]glyoxylic acid amide as inhibitor of pde4
06/07/2012WO2012072512A1 N-cyclobutyl-imidazopyridine or -pyrazolopyridine carboxamides as trpv1 antagonists
06/07/2012WO2012072200A1 3-hetaryl-substituted pyrrolo[2,3-b]pyridine derivatives as pdk1 inhibitors
06/07/2012WO2012026766A3 Novel heterocyclic compound, and composition for treating inflammatory diseases using same
06/07/2012WO2012026765A3 Novel heterocyclic compound, and composition for treating inflammatory diseases using same
06/07/2012WO2010073128A3 Fused imidazole derivatives as trpv3 antagonist
06/07/2012US20120142928 Process for the preparation of cathepsin s inhibitors
06/07/2012US20120142915 Cyclopropyl mida boronate
06/07/2012US20120142733 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2
06/07/2012US20120142721 Small molecule inhibitors of polynucleotide kinase/phosphatase, poly(adp-ribose) polymerase and uses thereof
06/07/2012US20120142699 Trazodone and trazodone hydrochloride in purified form
06/07/2012US20120142687 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity
06/07/2012US20120142685 Organic compounds
06/07/2012US20120142678 Novel compound useful for the treatment of degenerative and inflammatory diseases
06/07/2012US20120142673 Pyrido-, Pyrazo- and Pyrimido-Pyrimidine Derivatives as mTOR Inhibitors
06/07/2012US20120142672 Heterocyclic compound and use thereof
06/07/2012US20120142670 N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy
06/07/2012US20120142669 N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy
06/07/2012US20120142665 Triazolopyridine compounds
06/07/2012US20120142635 Oxazolidinone-quinolone hybrid antibiotics
06/07/2012US20120142633 Methylpyrrolopyridinecarboxamides
06/07/2012CA2819840A1 3-substituted-6-(pyridinylmethoxy)-pyrrolopyridine compounds
06/07/2012CA2819734A1 Carbocycle-substituted purine and 7-deazapurine compounds
06/07/2012CA2819518A1 3-hetaryl-substituted pyrrolo[2,3-b]pyridine derivatives as pdk1 inhibitors
06/07/2012CA2819508A1 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2
06/07/2012CA2819501A1 Hybrid cyclic libraries and screens thereof
06/06/2012EP2460796A1 Indole derivative
06/06/2012EP2460794A1 Pharmaceutical composition containing fused hetero-ring derivative
06/06/2012EP2459561A1 Poly (adp-ribose) polymerase (parp) inhibitors
06/06/2012EP2459560A1 Ring-annulated dihydropyrrolo[2,l-a]isoquinolines
06/06/2012EP2459559A1 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase ck2
06/06/2012EP2459558A2 Compounds and compositions as syk kinase inhibitors
06/06/2012EP2459557A1 Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals
06/06/2012EP2459556A1 2, 7 -naphthyridin- 1 -one derivatives as syk kinase inhibitors
06/06/2012EP2459197A1 Compounds for the reduction of -amyloid production
06/06/2012EP2458991A1 Radiolabeled cgrp antagonists
06/06/2012EP2334674B1 Pyridazino- pyridinone compounds for the treatment of protein kinase mediated diseases.
06/06/2012EP2205599B1 Cgrp antagonists
06/06/2012EP2174934B1 Oxopyrazine derivative and herbicide
06/06/2012EP2029532B1 Piperazine enamines as antiviral agents
06/06/2012DE102010053347A1 3-Hetaryl-substituierte Pyrrolo[2,3-b] pyridin-derivative als PDK1-Inhibitoren 3-hetaryl-substituted pyrrolo [2,3-b] pyridine-derivative as PDK1 inhibitors
06/06/2012CN102485726A Method for preparing 1-R-1'-spiro-(piperidine-4,4'-quinoline)-2'(3'-hydrogen)ketone
06/06/2012CN102485725A Diazacyclo bridged medicine template, preparation method thereof and application thereof
06/06/2012CN102485724A Substituted thiazolyl pyrazolo pyridine compound and medical purpose thereof
06/06/2012CN101830900B Olprinone hydrochloric acid crystal form and preparation method thereof
06/06/2012CN101787024B Quinoline
06/06/2012CN101663301B Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
06/06/2012CN101657449B Diphenyl-dihydro-imidazopyridinones
06/06/2012CN101472904B Diazepan derivatives modulators of chemokine receptors
06/05/2012US8193357 Androgen receptor modulator compounds
06/05/2012US8193356 Heterocycle compound, and production process and application thereof
06/05/2012US8193228 Substituted imidazole as bombesin receptor subtype-3 modulators
06/05/2012US8193207 Lactam compounds and methods of using the same
06/05/2012US8193186 Pyridopyrazines and the use thereof as kinase inhibitors
06/05/2012US8193185 Administering a tryptanthrin compound, e.g., 8-nitroindolo[2,1-b]quinazoline-6,12-dione, to potentiate the immune response to an antigen; immunostimulants; small molecule immune potentiators; immunotherapy for infectious diseases; anticarcinogenic agents; vaccine adjuvant compositions and kits
06/05/2012US8193179 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
06/05/2012CA2539349C 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
06/05/2012CA2529443C Pyrido[2,1-a]-isoquinoline derivatives as dpp-iv inhibitors
05/2012
05/31/2012WO2012071519A1 Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture
05/31/2012WO2012071501A1 Benzoxazepines asn inhibitors of p13k/m tor and methods of their use and manufacture
05/31/2012WO2012071336A1 Salts and crystalline forms of an apoptosis-inducing agent
05/31/2012WO2012070649A1 Highly-soluble pyrroloquinoline quinone salt and method for producing same
05/31/2012WO2012070114A1 Sulfamide derivative having npy y5 receptor antagonism
05/31/2012WO2012069917A1 Bicyclic gpr119 modulators
05/31/2012WO2012069852A1 Pharmaceutical compounds as inhibitors of sphingosine kinase
05/31/2012WO2012069202A1 Imidazo [1,2-b] pyridazine and imidazo [4,5-b] pyridine derivatives as jak inhibitors
05/31/2012WO2012068622A1 Compounds for treating respiratory syncytial virus infections
05/31/2012WO2012044043A3 Novel method of preparing benzoimidazole derivatives
05/31/2012WO2012021444A8 Besylate salt of a btk inhibitor
05/31/2012US20120136154 Processes for the preparation of substituted tetrahydro beta-carbolines
1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 646